| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.1M | — | +32.9% |
| Cost of Revenue | $3.6M | — | +21.3% |
| R&D Expense | $5.1M | — | +5.1% |
| SG&A Expense | $19.4M | — | +1.7% |
| Operating Income | -$8.8M | — | +43.4% |
| Pre-tax Income | -$10.9M | — | +36.4% |
| Income Tax | $74K | — | +89.7% |
| Net Income | -$10.9M | — | +36.2% |
| EPS (Basic) | -$0.69 | — | +34.3% |
| EPS (Diluted) | -$0.69 | — | +34.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $185.4M | -4.7% | -27.1% |
| Accounts Receivable | $16.1M | +11.4% | +97.7% |
| Current Assets | $209.1M | -3.4% | -27.3% |
| Total Assets | $287.3M | -2.1% | -20.2% |
| Current Liabilities | $184.3M | +2.0% | +172.2% |
| Long-term Debt | $128.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.7M | — | +38.4% |
| Capital Expenditures | $363K | — | -69.5% |
| Investing Cash Flow | -$965K | — | +44.1% |
| Financing Cash Flow | -$485K | — | +90.2% |
| Free Cash Flow | -$7.1M | — | +41.4% |
| +1.6% |
| Total Liabilities | $185.1M | +1.9% | -8.8% |
| Stockholders' Equity | $102.2M | -8.6% | -34.8% |